Group One Trading
SVA

Group One Trading’s Sinovac Biotech, Ltd SVA Stock Holding History

Group One Trading’s Portfolio SVA Stock Details SVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-412
Closed -$2.67K – 7638
2024
Q2 		$2.67K Hold
412
– – ﹤0.01% 6148
2024
Q1 		$2.67K Buy
+412
New +$2.67K ﹤0.01% 6421
2023
Q4 		– Sell
-412
Closed -$2.67K – 8537
2023
Q3 		$2.67K Hold
412
– – ﹤0.01% 6955
2023
Q2 		$2.67K Buy
+412
New +$2.67K ﹤0.01% 6993
2022
Q4 		– Sell
-412
Closed -$27K – 8572
2022
Q3 		$27K Hold
412
– – ﹤0.01% 5896
2022
Q2 		$3K Buy
+412
New +$3K ﹤0.01% 7369
2022
Q1 		– Sell
-412
Closed – – 9222
2021
Q4 		$0 Hold
412
– – ﹤0.01% 9271
2021
Q3 		$0 Hold
412
– – ﹤0.01% 9204
2021
Q2 		$3K Hold
412
– – ﹤0.01% 7912
2021
Q1 		$27K Hold
412
– – ﹤0.01% 6627
2020
Q4 		$3K Hold
412
– – ﹤0.01% 6217
2020
Q3 		$3K Hold
412
– – ﹤0.01% 5796
2020
Q2 		$3K Hold
412
– – ﹤0.01% 5534
2020
Q1 		$3K Hold
412
– – ﹤0.01% 4942
2019
Q4 		$3K Hold
412
– – ﹤0.01% 4877
2019
Q3 		$3K Hold
412
– – ﹤0.01% 4898
2019
Q2 		$3K Hold
412
– – ﹤0.01% 4738
2019
Q1 		$3K Hold
412
– – ﹤0.01% 4562
2018
Q4 		$3K Hold
412
– – ﹤0.01% 4633
2018
Q3 		$3K Hold
412
– – ﹤0.01% 5004
2018
Q2 		$3K Sell
412
-1,020
-71% -$8.02K ﹤0.01% 4928
2018
Q1 		$12K Sell
1,432
-26,058
-95% -$215K ﹤0.01% 4284
2017
Q4 		$217K Sell
27,490
-3,771
-12% -$28.2K ﹤0.01% 2875
2017
Q3 		$220K Buy
31,261
+400
+1% +$2.73K ﹤0.01% 2702
2017
Q2 		$208K Buy
30,861
+29,068
+1,621% +$159K ﹤0.01% 2620
2017
Q1 		$10K Sell
1,793
-2,500
-58% -$14.5K ﹤0.01% 4140
2016
Q4 		$25K Buy
+4,293
New +$25.8K ﹤0.01% 3625
2016
Q1 		– Sell
-9
Closed -$54 – 5567
2015
Q4 		$0 Sell
9
-293
-97% -$1.58K ﹤0.01% 5654
2015
Q3 		$2K Hold
302
– – ﹤0.01% 4736
2015
Q2 		$2K Sell
302
-13,264
-98% -$70.1K ﹤0.01% 4728
2015
Q1 		$67K Sell
13,566
-1,361
-9% -$6.7K ﹤0.01% 3182
2014
Q4 		$78K Buy
14,927
+8,232
+123% +$42K ﹤0.01% 3051
2014
Q3 		$32K Sell
6,695
-14,896
-69% -$80K ﹤0.01% 3851
2014
Q2 		$122K Sell
21,591
-3,661
-14% -$22.2K ﹤0.01% 2802
2014
Q1 		$182K Buy
25,252
+24,518
+3,340% +$162K ﹤0.01% 2526
2013
Q4 		$4K Sell
734
-825
-53% -$4.97K ﹤0.01% 4959
2013
Q3 		$9K Sell
1,559
-3,450
-69% -$16.5K ﹤0.01% 4558
2013
Q2 		$20K Buy
+5,009
New +$18.6K ﹤0.01% 4098

Other funds holding SVA

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
NAH
Neumann Advisory (HK) Central, Hong Kong $356M AUM 37.48% 1-Year Est. Return
HI
Horizon Investments Charlotte, North Carolina $8.92B AUM 25.62% 1-Year Est. Return

Group One Trading's SVA Position: Q3 2024 in Review

Group One Trading sold out of Sinovac Biotech, Ltd (SVA) in Q3 2024, closing a stake of 412 shares — an estimated $2.67K sold.

Group One Trading first reported a position in SVA in Q2 2013 and held it in 38 quarters. The position peaked at $220K in Q3 2017. 9 funds tracked by Wall St. Rank hold SVA as of Q3 2024.

  • Group One Trading reported no remaining Sinovac Biotech, Ltd position as of Q3 2024 after selling out during the quarter.
  • Group One Trading sold 412 Sinovac Biotech, Ltd shares in Q3 2024, an estimated $2.67K.
  • Group One Trading first reported a position in Sinovac Biotech, Ltd in Q2 2013 and held it in 38 quarters.
  • Group One Trading's Sinovac Biotech, Ltd position peaked at $220K in Q3 2017.
  • 9 funds tracked by Wall St. Rank held Sinovac Biotech, Ltd as of Q3 2024.

Based on Group One Trading's 13F filing for Q3 2024, filed 14 Nov 2024.